AbClon Inc (174900) - Total Liabilities

Latest as of June 2026: ₩11.43 Billion KRW ≈ $7.75 Million USD

Based on the latest financial reports, AbClon Inc (174900) has total liabilities worth ₩11.43 Billion KRW (≈ $7.75 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of AbClon Inc to evaluate the company's liquid asset resilience ratio.

AbClon Inc - Total Liabilities Trend (2015–2025)

This chart illustrates how AbClon Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 174900 asset base.

AbClon Inc Competitors by Total Liabilities

The table below lists competitors of AbClon Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Mitra Pinasthika Mustika Tbk JK:MPMX	Indonesia	Rp2.94 Trillion
Springsnow Food Group Co Ltd SHG:605567	China	CN¥1.20 Billion
Capital A Berhad KLSE:5099	Malaysia	RM3.92 Billion
V Zug Holding Ag SW:VZUG	Switzerland	CHF164.56 Million
Addcn Technology Co Ltd TWO:5287	Taiwan	NT$1.79 Billion
Avjennings Ltd AU:AVJ	Australia	AU$391.73 Million
Shanghai Dragonnet Tech SHE:300245	China	CN¥254.08 Million

Liability Composition Analysis (2015–2025)

This chart breaks down AbClon Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 174900 equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.89	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AbClon Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AbClon Inc (2015–2025)

The table below shows the annual total liabilities of AbClon Inc from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩10.31 Billion ≈ $6.99 Million	-45.10%
2024-12-31	₩18.78 Billion ≈ $12.72 Million	+3.24%
2023-12-31	₩18.19 Billion ≈ $12.33 Million	+4.18%
2022-12-31	₩17.46 Billion ≈ $11.83 Million	+66.76%
2021-12-31	₩10.47 Billion ≈ $7.09 Million	-3.07%
2020-12-31	₩10.80 Billion ≈ $7.32 Million	-6.81%
2019-12-31	₩11.59 Billion ≈ $7.85 Million	+15.84%
2018-12-31	₩10.00 Billion ≈ $6.78 Million	+188.10%
2017-12-31	₩3.47 Billion ≈ $2.35 Million	-13.84%
2016-12-31	₩4.03 Billion ≈ $2.73 Million	+40.95%
2015-12-31	₩2.86 Billion ≈ $1.94 Million	--

About AbClon Inc

KQ:174900 Korea Biotechnology

Market Cap

$264.12 Million

₩389.74 Billion KRW

Market Cap Rank

#15523 Global

#528 in Korea

Share Price

₩19560.00

Change (1 day)

-2.93%

52-Week Range

₩15010.00 - ₩89100.00

All Time High

₩90600.00